• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估影响上皮性卵巢癌预后的社会地理和生活方式因素:一项基于密苏里州县健康排名的回顾性研究。

Assessing the Socio-geographic and lifestyle Factors Impacting Epithelial Ovarian Cancer Outcomes: A Retrospective Study Based on County Health Ranking in Missouri.

作者信息

Goldenberg Carlye, Krell Kavita, Miranda Edgar Diaz, Ko Sooah, Demirchian Maya, Dyer Grace Anne, Hunter Mark, Tuller Erin, Hull Amanda, Lei Lei

机构信息

School of Medicine, University of Missouri. Columbia, Missouri, 65201.

Department of Obstetrics, Gynecology and Women's Health, School of Medicine, University of Missouri. Columbia, Missouri, 65201.

出版信息

medRxiv. 2025 Jun 20:2025.06.18.25329863. doi: 10.1101/2025.06.18.25329863.

DOI:10.1101/2025.06.18.25329863
PMID:40585129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12204272/
Abstract

OBJECTIVE

This study examined how obesity, smoking, and pregnancy history, characterized as lifestyle factors, are associated with survival of epithelial ovarian cancer, and investigated whether epithelial ovarian cancer presentation, survival, and cancer recurrence are affected by patient home geographic location.

METHODS

A retrospective analysis was conducted on all patients with epithelial ovarian cancer treated at the University of Missouri and Ellis Fischel Cancer Center between 2008 and 2023. Patient charts were reviewed for cancer history, lifestyle factors, patient status, laboratory values, and residential zip codes which were categorized using Missouri ZIP Health Rankings. Survival, cox univariate and multivariate logistic regression, and association analyses were performed.

RESULTS

In this cohort, stage at diagnosis, histologic type, age at diagnosis and initial CA125 proved to be significant predictors of survival, while lifestyle factors including BMI, smoking, and pregnancy were not. Notably, patients residing in communities with the lowest zip code health rankings experienced higher rates of cancer recurrence, despite a lower overall number of cases compared to higher-ranked communities.

CONCLUSION

Although the lifestyle factors investigated in this study were not significantly associated with survival, a geographic disparity in recurrence rates and total cases was clear, suggesting possible underdiagnosis and barriers to accessing care in lower ranked zip codes. These findings emphasize an evident need to further investigate community-specific healthcare access and delivery, as well as other lifestyle factors that may be contributing to these differences.

摘要

目的

本研究探讨了肥胖、吸烟和妊娠史等生活方式因素与上皮性卵巢癌生存率之间的关联,并调查了患者的家庭地理位置是否会影响上皮性卵巢癌的发病情况、生存率及癌症复发情况。

方法

对2008年至2023年期间在密苏里大学和埃利斯·菲舍尔癌症中心接受治疗的所有上皮性卵巢癌患者进行回顾性分析。查阅患者病历,了解癌症病史、生活方式因素、患者状况、实验室检查值以及居住邮政编码,并根据密苏里州邮政编码健康排名进行分类。进行了生存分析、Cox单因素和多因素逻辑回归分析以及关联分析。

结果

在该队列中,诊断时的分期、组织学类型、诊断年龄和初始CA125被证明是生存的重要预测因素,而包括体重指数、吸烟和妊娠在内的生活方式因素则不是。值得注意的是,居住在邮政编码健康排名最低社区的患者癌症复发率较高,尽管与排名较高的社区相比,病例总数较少。

结论

尽管本研究中调查的生活方式因素与生存率没有显著关联,但复发率和病例总数在地理上存在明显差异,这表明在排名较低的邮政编码地区可能存在诊断不足和就医障碍。这些发现强调了迫切需要进一步调查社区特定的医疗服务获取和提供情况,以及可能导致这些差异的其他生活方式因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/12204272/af6c7df57623/nihpp-2025.06.18.25329863v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/12204272/8819778dbb8c/nihpp-2025.06.18.25329863v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/12204272/436c1b46a553/nihpp-2025.06.18.25329863v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/12204272/659501e1c343/nihpp-2025.06.18.25329863v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/12204272/af6c7df57623/nihpp-2025.06.18.25329863v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/12204272/8819778dbb8c/nihpp-2025.06.18.25329863v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/12204272/436c1b46a553/nihpp-2025.06.18.25329863v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/12204272/659501e1c343/nihpp-2025.06.18.25329863v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d59e/12204272/af6c7df57623/nihpp-2025.06.18.25329863v1-f0004.jpg

相似文献

1
Assessing the Socio-geographic and lifestyle Factors Impacting Epithelial Ovarian Cancer Outcomes: A Retrospective Study Based on County Health Ranking in Missouri.评估影响上皮性卵巢癌预后的社会地理和生活方式因素:一项基于密苏里州县健康排名的回顾性研究。
medRxiv. 2025 Jun 20:2025.06.18.25329863. doi: 10.1101/2025.06.18.25329863.
2
Taxane monotherapy regimens for the treatment of recurrent epithelial ovarian cancer.紫杉烷类单药治疗方案用于复发性上皮性卵巢癌。
Cochrane Database Syst Rev. 2022 Jul 12;7(7):CD008766. doi: 10.1002/14651858.CD008766.pub3.
3
Impact of residual disease as a prognostic factor for survival in women with advanced epithelial ovarian cancer after primary surgery.原发性手术后晚期上皮性卵巢癌患者残留病灶对生存预后的影响。
Cochrane Database Syst Rev. 2022 Sep 26;9(9):CD015048. doi: 10.1002/14651858.CD015048.pub2.
4
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
5
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
6
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
7
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
9
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Paradigm Shift: A Comprehensive Review of Ovarian Cancer Management in an Era of Advancements.范式转变:先进时代卵巢癌管理的全面综述。
Int J Mol Sci. 2024 Feb 3;25(3):1845. doi: 10.3390/ijms25031845.
2
Developments in Genetics: Better Management of Ovarian Cancer Patients.遗传学的发展:更好地管理卵巢癌患者。
Int J Mol Sci. 2023 Nov 5;24(21):15987. doi: 10.3390/ijms242115987.
3
Epidemiology and risk factors for ovarian cancer.卵巢癌的流行病学及危险因素
Prz Menopauzalny. 2023 Jun;22(2):93-104. doi: 10.5114/pm.2023.128661. Epub 2023 Jun 14.
4
Parity is associated with better prognosis in ovarian germ cell tumors, but not in other ovarian cancer subtypes.在卵巢生殖细胞肿瘤中,均等性与更好的预后相关,但在其他卵巢癌亚型中则不然。
Int J Cancer. 2022 Mar 1;150(5):773-781. doi: 10.1002/ijc.33844. Epub 2021 Oct 28.
5
Initial Ca 125 Value as a Predictive Marker for High-grade Serous Ovarian Cancer.初始 CA125 值可作为预测高级别浆液性卵巢癌的标志物。
J Coll Physicians Surg Pak. 2021 Jun;31(6):651-656. doi: 10.29271/jcpsp.2021.06.651.
6
Impact of parity on the incidence of ovarian cancer subtypes: a population-based case-control study.生育对卵巢癌亚型发病的影响:基于人群的病例对照研究。
Acta Oncol. 2021 Jul;60(7):850-855. doi: 10.1080/0284186X.2021.1919754. Epub 2021 May 17.
7
Ovarian Cancer Survival in Missouri, 1996-2014.1996 - 2014年密苏里州的卵巢癌生存率
Mo Med. 2018 Nov-Dec;115(6):542-547.
8
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
9
Obesity and ovarian cancer risk: A systematic review.肥胖与卵巢癌风险:一项系统综述。
Post Reprod Health. 2017 Dec;23(4):183-198. doi: 10.1177/2053369117709225. Epub 2017 Jul 18.
10
Measuring Subcounty Differences in Population Health Using Hospital and Census-Derived Data Sets: The Missouri ZIP Health Rankings Project.利用医院和人口普查数据集衡量县级以下人口健康的差异:密苏里州邮政编码健康排名项目。
J Public Health Manag Pract. 2018 Jul/Aug;24(4):340-349. doi: 10.1097/PHH.0000000000000578.